CLINICAL BENEFITS OF FINERENONE FOR CHRONIC KIDNEY DISEASE IN PATIENTS WITH FRAILTY (INCLUDING PREFRAILTY) OR UNDERNUTRITION

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 

 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

  Back
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/50fb9a495efe782800458a90cd543b4f.pdf
CLINICAL BENEFITS OF FINERENONE FOR CHRONIC KIDNEY DISEASE IN PATIENTS WITH FRAILTY (INCLUDING PREFRAILTY) OR UNDERNUTRITION

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Daisuke
Mori
Daisuke Mori mori@osakah.johas.go.jp Osaka Rosai Hospital Nephrology Sakai Japan *
Hirokazu Kouda hkouda0408@osakah.johas.go.jp Osaka Rosai Hospital Nephrology Sakai Japan -
Ai Nagasawa koshian0718@osakah.johas.go.jp Osaka Rosai Hospital Nephrology Sakai Japan -
Yoshito Ohtomo yoshitootomo@osakah.johas.go.jp Osaka Rosai Hospital Nephrology Sakai Japan -
Yusuke Sumitani y.sumitani@osakah.johas.go.jp Osaka Rosai Hospital Nephrology Sakai Japan -
Hiroki Yoshida yoshhi1844@osakah.johas.go.jp Osaka Rosai Hospital Nephrology Sakai Japan -
Shinjirou Tamai stama@osakah.johas.go.jp Osaka Rosai Hospital Nephrology Sakai Japan -
Hiroki Nomi hiroki.nomi@osakah.johas.go.jp Osaka Rosai Hospital Nephrology Sakai Japan -
Katsuyuki Nagatoya katsuyuki@osakah.johas.go.jp Osaka Rosai Hospital Nephrology Sakai Japan -
Atsushi Yamauchi ayamauchi@osakah.johas.go.jp Osaka Rosai Hospital Nephrology Sakai Japan -